{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:04:06Z","timestamp":1772445846058,"version":"3.50.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07747-5","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:35:04Z","timestamp":1771616104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proteomics profiling of serum and liver in GSD Ia and Ib patients: insights into complication mechanisms and circulation biomarkers"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4802-0644","authenticated-orcid":false,"given":"Ruiqi","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8167-5952","authenticated-orcid":false,"given":"Candelas","family":"Gross-Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6004-2398","authenticated-orcid":false,"given":"Albert","family":"Gerding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5550-2364","authenticated-orcid":false,"given":"Adam M.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4117-7833","authenticated-orcid":false,"given":"Maaike H.","family":"Oosterveer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7259-1095","authenticated-orcid":false,"given":"Terry G. J.","family":"Derks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7900-5917","authenticated-orcid":false,"given":"Vincent E.","family":"de Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3477-0770","authenticated-orcid":false,"given":"M. Rebecca","family":"Heiner-Fokkema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6274-3633","authenticated-orcid":false,"given":"Barbara M.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0066-3720","authenticated-orcid":false,"given":"Justina C.","family":"Wolters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"1","key":"7747_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/bf02679993","volume":"161","author":"PJ Lee","year":"2002","unstructured":"Lee PJ. Glycogen storage disease type I: pathophysiology of liver adenomas. Eur J Pediatr Suppl. 2002;161(1):46\u201349. https:\/\/doi.org\/10.1007\/bf02679993.","journal-title":"Eur J Pediatr Suppl"},{"issue":"11","key":"7747_CR2","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.3390\/nu13113828","volume":"13","author":"TGJ Derks","year":"2021","unstructured":"Derks TGJ, Rodriguez-Buritica DF, Ahmad A, et al. Glycogen storage disease type Ia: current management options, burden and unmet needs. Nutrients. 2021;13(11):3828. https:\/\/doi.org\/10.3390\/nu13113828.","journal-title":"Nutrients"},{"issue":"1","key":"7747_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1873-3468.13666","volume":"594","author":"SW Sim","year":"2020","unstructured":"Sim SW, Weinstein DA, Lee YM, Jun HS. Glycogen storage disease type Ib: role of glucose-6-phosphate transporter in cell metabolism and function. FEBS Lett. 2020;594(1):3\u201318. https:\/\/doi.org\/10.1002\/1873-3468.13666.","journal-title":"FEBS Lett"},{"issue":"251","key":"7747_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1136\/adc.47.251.41","volume":"47","author":"J Fernandes","year":"1972","unstructured":"Fernandes J, Pikaar NA. Ketosis in hepatic glycogenosis. Arch Dis Child. 1972;47(251):41\u201346. https:\/\/doi.org\/10.1136\/adc.47.251.41.","journal-title":"Arch Dis Child"},{"issue":"6","key":"7747_CR5","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0022-3476(73)80531-1","volume":"83","author":"A Binkiewicz","year":"1973","unstructured":"Binkiewicz A, Senior B. Decreased ketogenesis in von Gierke\u2019s disease (type I glycogenosis). J Pediatr. 1973;83(6):973\u201378. https:\/\/doi.org\/10.1016\/S0022-3476(73)80531-1.","journal-title":"J Pediatr"},{"issue":"11","key":"7747_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/gim.2014.128","volume":"16","author":"PS Kishnani","year":"2014","unstructured":"Kishnani PS, Austin SL, Abdenur JE, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014;16(11):1\u201329. https:\/\/doi.org\/10.1038\/gim.2014.128.","journal-title":"Genet Med"},{"issue":"3","key":"7747_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ymgme.2017.01.003","volume":"120","author":"GY Kim","year":"2017","unstructured":"Kim GY, Lee YM, Kwon JH, et al. Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-\u03b1 activity restored are at risk of developing hepatic tumors. Mol Genet Metab. 2017;120(3):229\u201334. https:\/\/doi.org\/10.1016\/j.ymgme.2017.01.003.","journal-title":"Mol Genet Metab"},{"issue":"9","key":"7747_CR8","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1074\/jbc.274.9.5532","volume":"274","author":"H Hiraiwa","year":"1999","unstructured":"Hiraiwa H, Pan CJ, Lin B, et al. Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b. J Biol Chem. 1999;274(9):5532\u201336. https:\/\/doi.org\/10.1074\/jbc.274.9.5532.","journal-title":"J Biol Chem"},{"issue":"8","key":"7747_CR9","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.gim.2022.04.001","volume":"24","author":"SC Gr\u00fcnert","year":"2022","unstructured":"Gr\u00fcnert SC, Derks TGJ, Adrian K, et al. Efficacy and safety of empagliflozin in glycogen storage disease type Ib: data from an international questionnaire. Genet Med. 2022;24(8):1781\u201388. https:\/\/doi.org\/10.1016\/j.gim.2022.04.001.","journal-title":"Genet Med"},{"issue":"2","key":"7747_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1067\/mpd.2000.105232","volume":"137","author":"G Visser","year":"2000","unstructured":"Visser G, Rake JP, Fernandes J, et al. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European study on glycogen storage disease type I. J Pediatr. 2000;137(2):187\u201391. https:\/\/doi.org\/10.1067\/mpd.2000.105232.","journal-title":"J Pediatr"},{"issue":"5","key":"7747_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10545-017-0039-1","volume":"40","author":"F Peeks","year":"2017","unstructured":"Peeks F, Steunenberg TAH, de Boer F, et al. Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control. J Inherit Metab Dis. 2017;40(5):695\u2013702. https:\/\/doi.org\/10.1007\/s10545-017-0039-1.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"7747_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ymgme.2009.04.003","volume":"97","author":"B Sun","year":"2009","unstructured":"Sun B, Li S, Yang L, et al. Activation of glycolysis and apoptosis in glycogen storage disease type Ia. Mol Genet Metab. 2009;97(4):267\u201371. https:\/\/doi.org\/10.1016\/j.ymgme.2009.04.003.","journal-title":"Mol Genet Metab"},{"issue":"7","key":"7747_CR13","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/glycob\/cwr023","volume":"21","author":"B Hayee","year":"2011","unstructured":"Hayee B, Antonopoulos A, Murphy EJ, et al. G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction. Glycobiology. 2011;21(7):914\u201324. https:\/\/doi.org\/10.1093\/glycob\/cwr023.","journal-title":"Glycobiology"},{"issue":"2","key":"7747_CR14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jhep.2012.09.030","volume":"58","author":"J Calderaro","year":"2013","unstructured":"Calderaro J, Labrune P, Morcrette G, et al. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. J Hepatol. 2013;58(2):350\u201357. https:\/\/doi.org\/10.1016\/j.jhep.2012.09.030.","journal-title":"J Hepatol"},{"issue":"8","key":"7747_CR15","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s00535-013-0890-2","volume":"49","author":"LY Chiu","year":"2014","unstructured":"Chiu LY, Kishnani PS, Chuang TP, et al. Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers. J Gastroenterol. 2014;49(8):1274\u201384. https:\/\/doi.org\/10.1007\/s00535-013-0890-2.","journal-title":"J Gastroenterol"},{"key":"7747_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.metabol.2018.01.004","volume":"82","author":"N Ondruskova","year":"2018","unstructured":"Ondruskova N, Honzik T, Kolarova H, et al. Aberrant apolipoprotein C-III glycosylation in glycogen storage disease type III and IX. Metabolism. 2018;82:135\u201341. https:\/\/doi.org\/10.1016\/j.metabol.2018.01.004.","journal-title":"Metabolism"},{"issue":"7","key":"7747_CR17","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1021\/acs.jproteome.9b00309","volume":"18","author":"D Cangelosi","year":"2019","unstructured":"Cangelosi D, Resaz R, Petretto A, et al. A proteomic analysis of GSD-1a in mouse livers: evidence for metabolic reprogramming, inflammation, and macrophage polarization. J Proteome Res. 2019;18(7):2965\u201378. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00309.","journal-title":"J Proteome Res"},{"issue":"9","key":"7747_CR18","doi-asserted-by":"publisher","first-page":"dmm043364","DOI":"10.1242\/dmm.043364","volume":"13","author":"R Resaz","year":"2020","unstructured":"Resaz R, Cangelosi D, Morini M, et al. Circulating exosomal microRNAs as potential biomarkers of hepatic injury and inflammation in a murine model of glycogen storage disease type 1a. Dis Model Mech. 2020;13(9):dmm043364. https:\/\/doi.org\/10.1242\/dmm.043364.","journal-title":"Dis Model Mech"},{"key":"7747_CR19","doi-asserted-by":"publisher","first-page":"579981","DOI":"10.3389\/fendo.2020.579981","volume":"11","author":"L Hannibal","year":"2020","unstructured":"Hannibal L, Theimer J, Wingert V, et al. Metabolic profiling in human fibroblasts enables subtype clustering in glycogen storage disease. Front Endocrinol (Lausanne). 2020;11:579981. https:\/\/doi.org\/10.3389\/fendo.2020.579981.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"7747_CR20","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.ajhg.2021.04.013","volume":"108","author":"BG Ng","year":"2021","unstructured":"Ng BG, Sosicka P, Fenaille F, et al. A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction. Am J Hum Genet. 2021;108(6):1040\u201352. https:\/\/doi.org\/10.1016\/j.ajhg.2021.04.013.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"7747_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/jimd.12451","volume":"45","author":"T Mathis","year":"2022","unstructured":"Mathis T, Poms M, K\u00f6feler H, et al. Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I. J Inherit Metab Dis. 2022;45(2):235\u201347. https:\/\/doi.org\/10.1002\/jimd.12451.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"7747_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/jmd2.12304","volume":"63","author":"E Tallis","year":"2022","unstructured":"Tallis E, Karsenty CL, Grimes AB, et al. Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment. JIMD Rep. 2022;63(4):309\u201315. https:\/\/doi.org\/10.1002\/jmd2.12304.","journal-title":"JIMD Rep"},{"key":"7747_CR23","doi-asserted-by":"publisher","unstructured":"Colonetti K, Vairo PE, Siebert F, M, et al. Cytokine profiling in patients with hepatic glycogen storage disease: Are there clues for unsolved aspects? Cytokine. 2023;162:156088. https:\/\/doi.org\/10.1016\/j.cyto.2022.156088.","DOI":"10.1016\/j.cyto.2022.156088"},{"issue":"10","key":"7747_CR24","doi-asserted-by":"publisher","first-page":"100651","DOI":"10.1016\/j.jlr.2024.100651","volume":"65","author":"A Rossi","year":"2024","unstructured":"Rossi A, Ruoppolo M, Fedele R, et al. A specific serum lipid signature characterizes patients with glycogen storage disease type Ia. J Lipid Res. 2024;65(10):100651. https:\/\/doi.org\/10.1016\/j.jlr.2024.100651.","journal-title":"J Lipid Res"},{"issue":"3","key":"7747_CR25","doi-asserted-by":"publisher","first-page":"109045","DOI":"10.1016\/j.ymgme.2025.109045","volume":"144","author":"Y Lu","year":"2025","unstructured":"Lu Y, Tian J, Deng J, et al. Metabolic and proteomic profiles provide insights on mechanism of late onset Pompe disease. Mol Genet Metab. 2025;144(3):109045. https:\/\/doi.org\/10.1016\/j.ymgme.2025.109045.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"7747_CR26","doi-asserted-by":"publisher","first-page":"20658","DOI":"10.1038\/s41598-025-06272-7","volume":"15","author":"F Pirozzi","year":"2025","unstructured":"Pirozzi F, Amiri R, Luni C, et al. Multiomics approach provides insight into altered choline metabolism and liver injury in patients with glycogen storage disease type Ia. Sci Rep. 2025;15(1):20658. https:\/\/doi.org\/10.1038\/s41598-025-06272-7.","journal-title":"Sci Rep"},{"issue":"Suppl, 1","key":"7747_CR27","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1007\/s00431-002-1016-7","volume":"161","author":"JP Rake","year":"2002","unstructured":"Rake JP, Visser G, Labrune P, et al. Guidelines for management of glycogen storage disease type I - European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr. 2002;161(Suppl, 1):S112\u201319. https:\/\/doi.org\/10.1007\/s00431-002-1016-7.","journal-title":"Eur J Pediatr"},{"issue":"4","key":"7747_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jmd2.12414","volume":"65","author":"AB Schreuder","year":"2024","unstructured":"Schreuder AB, Overduin RJ, Peltenburg NC, de Boer L, Bodewes FAJA, Derks TGJ. Screening and surveillance of hepatocellular carcinoma by serum des-gamma-carboxy prothrombin in patients with glycogen storage disease type Ia. JIMD Rep. 2024;65(4):207\u201311. https:\/\/doi.org\/10.1002\/jmd2.12414.","journal-title":"JIMD Rep"},{"issue":"2","key":"7747_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00261-011-9721-1","volume":"37","author":"A Sakamoto","year":"2012","unstructured":"Sakamoto A, Hayashi H, Sakamoto I, et al. Multiple hepatocellular adenomas in a patient with glycogen storage disease type I: various enhancement patterns in MRI with Gd-EOB-DTPA. Abdom Imag. 2012;37(2):239\u201343. https:\/\/doi.org\/10.1007\/s00261-011-9721-1.","journal-title":"Abdom Imag"},{"issue":"6","key":"7747_CR30","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/ped.14202","volume":"62","author":"Y Okata","year":"2020","unstructured":"Okata Y, Hatakeyama T, Bitoh Y, Aida Y, Yuichiro T. Hepatocellular carcinoma with glycogen storage disease type 1a. Pediatr Int. 2020;62(6):744\u201345. https:\/\/doi.org\/10.1111\/ped.14202.","journal-title":"Pediatr Int"},{"issue":"D1","key":"7747_CR31","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol Y, Bai J, Bandla C, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50(D1):D543\u201352. https:\/\/doi.org\/10.1093\/nar\/gkab1038.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"7747_CR32","doi-asserted-by":"publisher","first-page":"bbaa112","DOI":"10.1093\/bib\/bbaa112","volume":"22","author":"M Liu","year":"2021","unstructured":"Liu M, Dongre A. Proper imputation of missing values in proteomics datasets for differential expression analysis. Brief Bioinform. 2021;22(3):bbaa112. https:\/\/doi.org\/10.1093\/bib\/bbaa112.","journal-title":"Brief Bioinform"},{"issue":"1","key":"7747_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2009","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009;26(1):139\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616.","journal-title":"Bioinformatics"},{"issue":"11","key":"7747_CR34","doi-asserted-by":"publisher","first-page":"e10427","DOI":"10.15252\/emmm.201910427","volume":"11","author":"PE Geyer","year":"2019","unstructured":"Geyer PE, Voytik E, Treit PV, et al. Plasma proteome profiling to detect and avoid sample-related biases in biomarker studies. EMBO Mol Med. 2019;11(11):e10427. https:\/\/doi.org\/10.15252\/emmm.201910427.","journal-title":"EMBO Mol Med"},{"key":"7747_CR35","doi-asserted-by":"publisher","unstructured":"Xia J, Broadhurst DI, Wilson M, Wishart DS. Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics. 2013;9(2):280\u201399. https:\/\/doi.org\/10.1007\/s11306-012-0482-9.","DOI":"10.1007\/s11306-012-0482-9"},{"issue":"2","key":"7747_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1182\/blood.V41.2.235.235","volume":"41","author":"EE Czapek","year":"1973","unstructured":"Czapek EE, Deykin D, Salzman EW. Platelet dysfunction in glycogen storage disease type I. Blood. 1973;41(2):235\u201347. https:\/\/doi.org\/10.1182\/blood.V41.2.235.235.","journal-title":"Blood"},{"issue":"3","key":"7747_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1651-2227.1968.tb04679.x","volume":"57","author":"GS Gilchrist","year":"1968","unstructured":"Gilchrist GS, Fine RN, Donnell GN. The hemostatic defect in glycogen storage disease, type 1. Acta Paediatr Scand. 1968;57(3):205\u201308. https:\/\/doi.org\/10.1111\/j.1651-2227.1968.tb04679.x.","journal-title":"Acta Paediatr Scand"},{"issue":"1","key":"7747_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/s0022-3476(74)80288-x","volume":"85","author":"DG Corby","year":"1974","unstructured":"Corby DG, Putnam CW, Greene HL. Impaired platelet function in glucose-6-phosphatase deficiency. J Pediatr. 1974;85(1):71\u201376. https:\/\/doi.org\/10.1016\/s0022-3476(74)80288-x.","journal-title":"J Pediatr"},{"issue":"1","key":"7747_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/adc.51.1.49","volume":"51","author":"RA Hutton","year":"1976","unstructured":"Hutton RA, Macnab AJ, Rivers RP. Defect of platelet function associated with chronic hypoglycaemia. Arch Dis Child. 1976;51(1):49\u201355. https:\/\/doi.org\/10.1136\/adc.51.1.49.","journal-title":"Arch Dis Child"},{"key":"7747_CR40","doi-asserted-by":"publisher","first-page":"101265","DOI":"10.1016\/j.molmet.2021.101265","volume":"53","author":"AM La Rose","year":"2021","unstructured":"La Rose AM, Bazioti V, Hoogerland JA, et al. Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia. Mol Metab. 2021;53:101265. https:\/\/doi.org\/10.1016\/j.molmet.2021.101265.","journal-title":"Mol Metab"},{"issue":"Suppl, 2","key":"7747_CR41","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1111\/j.1542-4758.2006.00119.x","volume":"10","author":"D Green","year":"2006","unstructured":"Green D. Coagulation cascade. Hemodial Int. 2006;10(Suppl, 2):S2\u20134. https:\/\/doi.org\/10.1111\/j.1542-4758.2006.00119.x.","journal-title":"Hemodial Int"},{"issue":"1","key":"7747_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","volume":"29","author":"JC Chapin","year":"2015","unstructured":"Chapin JC, Hajjar KA. Fibrinolysis and the control of blood coagulation. Blood Rev. 2015;29(1):17\u201324. https:\/\/doi.org\/10.1016\/j.blre.2014.09.003.","journal-title":"Blood Rev"},{"issue":"2","key":"7747_CR43","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11239-021-02456-w","volume":"52","author":"RM Camire","year":"2021","unstructured":"Camire RM. Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics. J Thromb Thrombolysis. 2021;52(2):383\u201390. https:\/\/doi.org\/10.1007\/s11239-021-02456-w.","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"7747_CR44","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10545-005-0184-9","volume":"28","author":"C M\u00fchlhausen","year":"2005","unstructured":"M\u00fchlhausen C, Schneppenheim R, Budde U, et al. Decreased plasma concentration of von Willebrand factor antigen (VWF: Ag) in patients with glycogen storage disease type Ia. J Inherit Metab Dis. 2005;28(6):945\u201350. https:\/\/doi.org\/10.1007\/s10545-005-0184-9.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"7747_CR45","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1182\/blood.V68.1.180.180","volume":"68","author":"GE Marti","year":"1986","unstructured":"Marti GE, Rick ME, Sidbury J, Gralnick HR. DDAVP infusion in five patients with type Ia glycogen storage disease and associated correction of prolonged bleeding times. Blood. 1986;68(1):180\u201384. https:\/\/doi.org\/10.1182\/blood.V68.1.180.180.","journal-title":"Blood"},{"issue":"1","key":"7747_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/BF00442739","volume":"143","author":"K Heyne","year":"1984","unstructured":"Heyne K, Hosenfeld D, Grote W, Schaub J. Glycogen storage disease type Ib: familial bleeding tendency. Eur J Pediatr. 1984;143(1):7\u20139. https:\/\/doi.org\/10.1007\/BF00442739.","journal-title":"Eur J Pediatr"},{"key":"7747_CR47","doi-asserted-by":"publisher","unstructured":"Gehlhaar A, Shouval DS, Santiago EG, et al. Immune dysregulation in glycogen storage disease 1b extends beyond neutropenia. Hum Immunol. https:\/\/doi.org\/10.1016\/j.humimm.2025.111268.","DOI":"10.1016\/j.humimm.2025.111268"},{"issue":"3","key":"7747_CR48","doi-asserted-by":"publisher","first-page":"218","DOI":"10.7326\/0003-4819-120-3-199402010-00008","volume":"120","author":"GM Talente","year":"1994","unstructured":"Talente GM, Coleman RA, Alter C, et al. Glycogen storage disease in adults. Ann Intern Med. 1994;120(3):218\u201326. https:\/\/doi.org\/10.7326\/0003-4819-120-3-199402010-00008.","journal-title":"Ann Intern Med"},{"issue":"2","key":"7747_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10545-005-7500-2","volume":"28","author":"LM Franco","year":"2005","unstructured":"Franco LM, Krishnamurthy V, Bali D, et al. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis. 2005;28(2):153\u201362. https:\/\/doi.org\/10.1007\/s10545-005-7500-2.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"7747_CR50","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/00005176-199703000-00008","volume":"24","author":"P Labrune","year":"1997","unstructured":"Labrune P, Trioche P, Duvaltier I, Chevalier P, Odi\u00e8vre M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr. 1997;24(3):276\u201379. https:\/\/doi.org\/10.1097\/00005176-199703000-00008.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"7747_CR51","doi-asserted-by":"publisher","first-page":"113634","DOI":"10.1016\/j.biopha.2022.113634","volume":"154","author":"AS Bhale","year":"2022","unstructured":"Bhale AS, Venkataraman K. Leveraging knowledge of HDLs major protein ApoA1: structure, function, mutations, and potential therapeutics. Biomed Pharmacother. 2022;154:113634. https:\/\/doi.org\/10.1016\/j.biopha.2022.113634.","journal-title":"Biomed Pharmacother"},{"key":"7747_CR52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.biochi.2013.08.027","volume":"96","author":"SF Ma\u00efga","year":"2014","unstructured":"Ma\u00efga SF, Kalopissis AD, Chabert M. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes. Biochimie. 2014;96:56\u201366. https:\/\/doi.org\/10.1016\/j.biochi.2013.08.027.","journal-title":"Biochimie"},{"issue":"4","key":"7747_CR53","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1172\/JCI109745","volume":"65","author":"PH Green","year":"1980","unstructured":"Green PH, Glickman RM, Riley JW, Apolipoprotein A-Iv QEH. Intestinal origin and distribution in plasma. J Clin Invest. 1980;65(4):911\u201319. https:\/\/doi.org\/10.1172\/JCI109745.","journal-title":"J Clin Invest"},{"issue":"1","key":"7747_CR54","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12933-022-01703-5","volume":"21","author":"A Rouland","year":"2022","unstructured":"Rouland A, Masson D, Lagrost L, Verg\u00e8s B, Gautier T, Bouillet B. Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review. Cardiovasc Diabetol. 2022;21(1):272. https:\/\/doi.org\/10.1186\/s12933-022-01703-5.","journal-title":"Cardiovasc Diabetol"},{"key":"7747_CR55","doi-asserted-by":"publisher","first-page":"154296","DOI":"10.1016\/j.metabol.2020.154296","volume":"109","author":"M Gao","year":"2020","unstructured":"Gao M, Yang C, Wang X, et al. ApoC2 deficiency elicits severe hypertriglyceridemia and spontaneous atherosclerosis: a rodent model rescued from neonatal death. Metabolism. 2020;109:154296. https:\/\/doi.org\/10.1016\/j.metabol.2020.154296.","journal-title":"Metabolism"},{"issue":"6","key":"7747_CR56","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.jacl.2018.08.010","volume":"12","author":"van Capelleveen Jc","year":"2018","unstructured":"van Capelleveen Jc, Lee SR, Verbeek R, et al. Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: the EPIC-Norfolk prospective population study. J Clin Lipidol. 2018;12(6):1493\u2013501.e11. https:\/\/doi.org\/10.1016\/j.jacl.2018.08.010.","journal-title":"J Clin Lipidol"},{"issue":"Suppl(Suppl)","key":"7747_CR57","doi-asserted-by":"publisher","first-page":"S156","DOI":"10.1194\/jlr.R800058-JLR200","volume":"50","author":"GS Getz","year":"2009","unstructured":"Getz GS, Reardon CA. Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall. J Lipid Res. 2009;50(Suppl):S156\u201361. https:\/\/doi.org\/10.1194\/jlr.R800058-JLR200.","journal-title":"J Lipid Res"},{"issue":"8","key":"7747_CR58","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1016\/s0021-9258(19)39557-2","volume":"265","author":"IJ Goldberg","year":"1990","unstructured":"Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, Bisgaier CL. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J Biol Chem. 1990;265(8):4266\u201372. https:\/\/doi.org\/10.1016\/s0021-9258(19)39557-2.","journal-title":"J Biol Chem"},{"key":"7747_CR59","doi-asserted-by":"publisher","unstructured":"Hsu CC, Kanter JE, Kothari V, Bornfeldt KE. Quartet of APOCs and the different roles they play in diabetes. Arterioscler Thromb Vasc Biol. 2023;43(7):1124\u201333. https:\/\/doi.org\/10.1161\/ATVBAHA.122.318290.","DOI":"10.1161\/ATVBAHA.122.318290"},{"key":"7747_CR60","doi-asserted-by":"publisher","unstructured":"Corbin LJ, Hughes DA, Chetwynd AJ, et al. Metabolic characterisation of disturbances in the APOC3\/triglyceride-rich lipoprotein pathway through sample-based recall by genotype [published correction appears in Metabolomics. Metabolomics. 2021 Jan 23;17(2):15. 10.1007\/s11306-020-01765-0. 2020;16(6):69.https:\/\/doi.org\/10.1007\/s11306-020-01689-9.","DOI":"10.1007\/s11306-020-01689-9"},{"issue":"41","key":"7747_CR61","doi-asserted-by":"publisher","first-page":"26388","DOI":"10.1074\/jbc.273.41.26388","volume":"273","author":"Y Huang","year":"1998","unstructured":"Huang Y, Liu XQ, Rall SC Jr, et al. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J Biol Chem. 1998;273(41):26388\u201393. https:\/\/doi.org\/10.1074\/jbc.273.41.26388.","journal-title":"J Biol Chem"},{"issue":"4","key":"7747_CR62","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/jimd.12380","volume":"44","author":"JA Hoogerland","year":"2021","unstructured":"Hoogerland JA, Peeks F, Hijmans BS, et al. Impaired very-low-density lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in glycogen storage disease type Ia. J Inherit Metab Dis. 2021;44(4):879\u201392. https:\/\/doi.org\/10.1002\/jimd.12380.","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl, 1","key":"7747_CR63","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1007\/s00431-002-0999-4","volume":"161","author":"JP Rake","year":"2002","unstructured":"Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr. 2002;161(Suppl, 1):S20\u201334. https:\/\/doi.org\/10.1007\/s00431-002-0999-4.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"7747_CR64","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1023\/a:1005605513534","volume":"23","author":"P Trioche","year":"2000","unstructured":"Trioche P, Francoual J, Capel L, Odi\u00e8vre M, Lindenbaum A, Labrune P. Apolipoprotein E polymorphism and serum concentrations in patients with glycogen storage disease type Ia. J Inherit Metab Dis. 2000;23(2):107\u201312. https:\/\/doi.org\/10.1023\/a:1005605513534.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"7747_CR65","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/ijms25031566","volume":"25","author":"J Dob\u00f3","year":"2024","unstructured":"Dob\u00f3 J, Kocsis A, Farkas B, Demeter F, Cervenak L, G\u00e1l P. The lectin pathway of the complement System-activation, regulation, disease connections and interplay with other (Proteolytic) systems. Int J Mol Sci. 2024;25(3):1566. https:\/\/doi.org\/10.3390\/ijms25031566.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"7747_CR66","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/cells14020088","volume":"14","author":"S Xiang","year":"2025","unstructured":"Xiang S, Yang L, He Y, et al. Alpha-1 antitrypsin as a regulatory protease inhibitor modulating inflammation and shaping the tumor microenvironment in cancer. Cells. 2025;14(2):88. https:\/\/doi.org\/10.3390\/cells14020088.","journal-title":"Cells"},{"issue":"15","key":"7747_CR67","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1182\/blood.2023020719","volume":"143","author":"SA Moellmer","year":"2024","unstructured":"Moellmer SA, Puy C, McCarty OJT. Biology of factor XI. Blood. 2024;143(15):1445\u201354. https:\/\/doi.org\/10.1182\/blood.2023020719.","journal-title":"Blood"},{"key":"7747_CR68","doi-asserted-by":"publisher","first-page":"1011084","DOI":"10.3389\/fimmu.2022.1011084","volume":"13","author":"M Asare-Werehene","year":"2022","unstructured":"Asare-Werehene M, McGuinty M, Vranjkovic A, et al. Longitudinal profiles of plasma gelsolin, cytokines and antibody expression predict COVID-19 severity and hospitalization outcomes. Front Immunol. 2022;13:1011084. https:\/\/doi.org\/10.3389\/fimmu.2022.1011084.","journal-title":"Front Immunol"},{"issue":"1","key":"7747_CR69","doi-asserted-by":"publisher","first-page":"17","DOI":"10.18632\/aging.100004","volume":"1","author":"G Perdomo","year":"2009","unstructured":"Perdomo G, Henry Dong H. Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging. Aging (Albany NY). 2009;1(1):17\u201327. https:\/\/doi.org\/10.18632\/aging.100004.","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"7747_CR70","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1021\/pr5011586","volume":"14","author":"J Marsillach","year":"2015","unstructured":"Marsillach J, Becker JO, Vaisar T, et al. Paraoxonase-3 is depleted from the high-density lipoproteins of autoimmune disease patients with subclinical atherosclerosis. J Proteome Res. 2015;14(5):2046\u201354. https:\/\/doi.org\/10.1021\/pr5011586.","journal-title":"J Proteome Res"},{"issue":"1","key":"7747_CR71","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/s42003-021-02630-z","volume":"4","author":"C Banfi","year":"2021","unstructured":"Banfi C, Baetta R, Barbieri SS, et al. Prenylcysteine oxidase 1, an emerging player in atherosclerosis. Commun Biol. 2021;4(1):1109. https:\/\/doi.org\/10.1038\/s42003-021-02630-z.","journal-title":"Commun Biol"},{"key":"7747_CR72","doi-asserted-by":"publisher","unstructured":"Sanjurjo L, Aran G, Roher N, Valledor AF, Sarrias MR. AIM\/CD5L: a key protein in the control of immune homeostasis and inflammatory disease. J Leukoc Biol. 2015;98(2):173\u201384. https:\/\/doi.org\/10.1189\/jlb.3RU0215-074R.","DOI":"10.1189\/jlb.3RU0215-074R"},{"issue":"6","key":"7747_CR73","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.cell.2015.10.068","volume":"163","author":"C Wang","year":"2015","unstructured":"Wang C, Yosef N, Gaublomme J, et al. CD5L\/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity. Cell. 2015;163(6):1413\u201327. https:\/\/doi.org\/10.1016\/j.cell.2015.10.068.","journal-title":"Cell"},{"issue":"8","key":"7747_CR74","doi-asserted-by":"publisher","first-page":"100512","DOI":"10.1016\/j.jhepr.2022.100512","volume":"4","author":"MPD Haring","year":"2022","unstructured":"Haring MPD, Peeks F, Oosterveer MH, et al. High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia. JHEP Rep. 2022;4(8):100512. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100512.","journal-title":"JHEP Rep"},{"issue":"5","key":"7747_CR75","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1002\/hep.32022","volume":"74","author":"MGS Rutten","year":"2021","unstructured":"Rutten MGS, Derks TGJ, Huijkman NCA, et al. Modeling phenotypic heterogeneity of glycogen storage disease type 1a liver disease in mice by somatic CRISPR\/CRISPR-associated protein 9-mediated gene editing. Hepatology. 2021;74(5):2491\u2013507. https:\/\/doi.org\/10.1002\/hep.32022.","journal-title":"Hepatology"},{"key":"7747_CR76","doi-asserted-by":"publisher","first-page":"1044902","DOI":"10.3389\/fonc.2022.1044902","volume":"12","author":"W Jia","year":"2022","unstructured":"Jia W, Wu Q, Yu X, et al. Prognostic values of ALDOB expression and 18F-FDG PET\/CT in hepatocellular carcinoma. Front Oncol. 2022;12:1044902. https:\/\/doi.org\/10.3389\/fonc.2022.1044902.","journal-title":"Front Oncol"},{"issue":"1","key":"7747_CR77","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1038\/s41467-021-24010-1","volume":"12","author":"DW Ho","year":"2021","unstructured":"Ho DW, Tsui YM, Chan LK, et al. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nat Commun. 2021;12(1):3684. https:\/\/doi.org\/10.1038\/s41467-021-24010-1.","journal-title":"Nat Commun"},{"issue":"3","key":"7747_CR78","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10545-011-9322-8","volume":"34","author":"K Bhattacharya","year":"2011","unstructured":"Bhattacharya K. Dietary dilemmas in the management of glycogen storage disease type I. J Inherit Metab Dis. 2011;34(3):621\u201329. https:\/\/doi.org\/10.1007\/s10545-011-9322-8.","journal-title":"J Inherit Metab Dis"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07747-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07747-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07747-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T09:14:25Z","timestamp":1772442865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07747-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7747"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07747-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"13 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data were obtained by experiment and data analysis. The tenets of the Declaration of Helsinki were followed. The Medical Ethical Committee of the University Medical Center Groningen (UMCG) stated that for retrospective, non-interventional studies the Medical Research Involving Human Subjects Act was not applicable and that further study approval by the Medical Ethical Committee was not required (METc 2019\/119).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"302"}}